Does International Flavors and Fragrances (IFF) Discounted Valuation Unlocks Opportunity?

1 hour ago 1

Soumya Eswaran

Wed, July 15, 2026 astatine 9:35 AM CDT 3 min read

Heartland Advisors, an concern absorption company, released its second-quarter 2026 capitalist missive for "Heartland Mid Cap Value Fund". A transcript tin beryllium downloaded here. Mid-cap stocks sharply roseate successful the 2nd quarter, driven by perceived AI beneficiaries, peculiarly successful Technology. The Fund returned 9.90% successful the quarter, compared to the Russell Midcap® Value Index's 13.40% return. The underperformance was driven by antagonistic banal enactment contempt Tech being 1 of the apical implicit instrumentality contributors. In the challenging environment, the Fund remains focused connected its disciplined attack to information selection. In addition, you tin cheque the Fund's apical 5 holdings to find its champion picks for 2026.

In its Q2 2026 capitalist letter, Heartland Mid Cap Value Fund highlighted International Flavors & Fragrances Inc. (NYSE:IFF). International Flavors & Fragrances Inc. (NYSE:IFF) is simply a specialty chemic institution that manufactures products crossed food, beverage, wellness and biosciences, scent, pharma solutions, and complementary adjacent products. On July 14, 2026, International Flavors & Fragrances Inc. (NYSE:IFF) closed astatine $74.67 per share, reflecting a marketplace capitalization of $19.06 billion. International Flavors & Fragrances Inc. (NYSE:IFF) posted a one-month instrumentality of -1.81%, portion its shares gained 0.61% implicit the past 52 weeks.

Heartland Mid Cap Value Fund stated the pursuing regarding International Flavors & Fragrances Inc. (NYSE:IFF) successful its Q2 2026 capitalist update:

"Materials. A caller deep-value holding is International Flavors & Fragrances Inc. (NYSE:IFF), a specialty constituent shaper that sells flavors, fragrances, and enzymes to food, beverage, idiosyncratic care, household products, and quality wellness merchandise manufacturers. This is an illustration of identifying a self-help accidental done bottom-up research.

For much than 2 years, absorption has worked connected streamlining IFF's portfolio and operations to absorption connected higher-margin businesses wherever it enjoys starring marketplace share, amended pricing power, charismatic growth, and importantly enhanced superior allocation flexibility. This strategy follows years of wayward superior allocation executed by anterior management. Today, IFF's gross is evenly divided crossed 3 segments. Taste accounts for 30% of profits, Health & Biosciences generates 37%, and Scent contributes 32%. In the Scent segment, IFF's pioneering of encapsulated fragrance exertion secured its enactment successful cloth care, a presumption present expanding into scent boosters, shampoos, and assemblage washes.

Driven by improving growth, margins, and escaped currency flow, we judge IFF is poised to operationally lucifer manufacture person Givaudan. Yet portion Givaudan trades astatine 19.14X guardant EBITDA, IFF trades astatine a steep discount of conscionable 12.23X. Highlighting management's assurance successful this valuation spread closing, the institution precocious instituted its archetypal stock buyback programme successful six years."

Read Entire Article